ABBVIE INC (1ABBV.MI) Fundamental Analysis & Valuation

BIT:1ABBV • US00287Y1091

Current stock price

180.75 EUR
+0.9 (+0.5%)
Last:

This 1ABBV.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. 1ABBV.MI Profitability Analysis

1.1 Basic Checks

  • 1ABBV had positive earnings in the past year.
  • In the past year 1ABBV had a positive cash flow from operations.
  • Each year in the past 5 years 1ABBV has been profitable.
  • 1ABBV had a positive operating cash flow in each of the past 5 years.
1ABBV.MI Yearly Net Income VS EBIT VS OCF VS FCF1ABBV.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 3.12%, 1ABBV is in the better half of the industry, outperforming 69.05% of the companies in the same industry.
  • 1ABBV has a better Return On Invested Capital (14.42%) than 86.90% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for 1ABBV is in line with the industry average of 13.21%.
  • The last Return On Invested Capital (14.42%) for 1ABBV is above the 3 year average (12.12%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.12%
ROE N/A
ROIC 14.42%
ROA(3y)3.28%
ROA(5y)5.23%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)12.12%
ROIC(5y)11.88%
1ABBV.MI Yearly ROA, ROE, ROIC1ABBV.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 100 -100

1.3 Margins

  • 1ABBV has a Profit Margin of 6.84%. This is in the better half of the industry: 1ABBV outperforms 69.05% of its industry peers.
  • In the last couple of years the Profit Margin of 1ABBV has declined.
  • With an excellent Operating Margin value of 34.23%, 1ABBV belongs to the best of the industry, outperforming 86.90% of the companies in the same industry.
  • In the last couple of years the Operating Margin of 1ABBV has grown nicely.
  • The Gross Margin of 1ABBV (71.62%) is better than 60.71% of its industry peers.
  • 1ABBV's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 34.23%
PM (TTM) 6.84%
GM 71.62%
OM growth 3Y-0.41%
OM growth 5Y2.75%
PM growth 3Y-30.39%
PM growth 5Y-7.2%
GM growth 3Y0.04%
GM growth 5Y1.44%
1ABBV.MI Yearly Profit, Operating, Gross Margins1ABBV.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

3

2. 1ABBV.MI Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), 1ABBV is creating some value.
  • The number of shares outstanding for 1ABBV remains at a similar level compared to 1 year ago.
  • Compared to 5 years ago, 1ABBV has about the same amount of shares outstanding.
  • The debt/assets ratio for 1ABBV is higher compared to a year ago.
1ABBV.MI Yearly Shares Outstanding1ABBV.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B
1ABBV.MI Yearly Total Debt VS Total Assets1ABBV.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50B 100B 150B

2.2 Solvency

  • 1ABBV has an Altman-Z score of 2.33. This is not the best score and indicates that 1ABBV is in the grey zone with still only limited risk for bankruptcy at the moment.
  • 1ABBV's Altman-Z score of 2.33 is in line compared to the rest of the industry. 1ABBV outperforms 53.57% of its industry peers.
  • 1ABBV has a debt to FCF ratio of 3.79. This is a good value and a sign of high solvency as 1ABBV would need 3.79 years to pay back of all of its debts.
  • 1ABBV has a Debt to FCF ratio of 3.79. This is in the better half of the industry: 1ABBV outperforms 77.38% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 3.79
Altman-Z 2.33
ROIC/WACC1.68
WACC8.59%
1ABBV.MI Yearly LT Debt VS Equity VS FCF1ABBV.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20B 40B 60B

2.3 Liquidity

  • A Current Ratio of 0.67 indicates that 1ABBV may have some problems paying its short term obligations.
  • 1ABBV has a Current ratio of 0.67. This is amonst the worse of the industry: 1ABBV underperforms 83.33% of its industry peers.
  • 1ABBV has a Quick Ratio of 0.67. This is a bad value and indicates that 1ABBV is not financially healthy enough and could expect problems in meeting its short term obligations.
  • 1ABBV has a Quick ratio of 0.56. This is amonst the worse of the industry: 1ABBV underperforms 83.33% of its industry peers.
Industry RankSector Rank
Current Ratio 0.67
Quick Ratio 0.56
1ABBV.MI Yearly Current Assets VS Current Liabilites1ABBV.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B

4

3. 1ABBV.MI Growth Analysis

3.1 Past

  • 1ABBV shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -1.19%.
  • 1ABBV shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -0.99% yearly.
  • Looking at the last year, 1ABBV shows a quite strong growth in Revenue. The Revenue has grown by 8.57% in the last year.
  • The Revenue has been growing slightly by 5.95% on average over the past years.
EPS 1Y (TTM)-1.19%
EPS 3Y-10.33%
EPS 5Y-0.99%
EPS Q2Q%25.46%
Revenue 1Y (TTM)8.57%
Revenue growth 3Y1.75%
Revenue growth 5Y5.95%
Sales Q2Q%10.04%

3.2 Future

  • The Earnings Per Share is expected to grow by 15.08% on average over the next years. This is quite good.
  • 1ABBV is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.43% yearly.
EPS Next Y48.4%
EPS Next 2Y28.14%
EPS Next 3Y22.01%
EPS Next 5Y15.08%
Revenue Next Year10.06%
Revenue Next 2Y9.09%
Revenue Next 3Y8.46%
Revenue Next 5Y6.43%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
1ABBV.MI Yearly Revenue VS Estimates1ABBV.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20B 40B 60B 80B
1ABBV.MI Yearly EPS VS Estimates1ABBV.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5 10 15 20

7

4. 1ABBV.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • 1ABBV is valuated rather expensively with a Price/Earnings ratio of 21.29.
  • Compared to the rest of the industry, the Price/Earnings ratio of 1ABBV indicates a somewhat cheap valuation: 1ABBV is cheaper than 77.38% of the companies listed in the same industry.
  • 1ABBV is valuated rather cheaply when we compare the Price/Earnings ratio to 27.53, which is the current average of the S&P500 Index.
  • With a Price/Forward Earnings ratio of 14.35, 1ABBV is valued correctly.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of 1ABBV indicates a rather cheap valuation: 1ABBV is cheaper than 89.29% of the companies listed in the same industry.
  • 1ABBV's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 37.95.
Industry RankSector Rank
PE 21.29
Fwd PE 14.35
1ABBV.MI Price Earnings VS Forward Price Earnings1ABBV.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of 1ABBV indicates a somewhat cheap valuation: 1ABBV is cheaper than 76.19% of the companies listed in the same industry.
  • 85.71% of the companies in the same industry are more expensive than 1ABBV, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 21.13
EV/EBITDA 15
1ABBV.MI Per share data1ABBV.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 -40

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The decent profitability rating of 1ABBV may justify a higher PE ratio.
  • A more expensive valuation may be justified as 1ABBV's earnings are expected to grow with 22.01% in the coming years.
PEG (NY)0.44
PEG (5Y)N/A
EPS Next 2Y28.14%
EPS Next 3Y22.01%

6

5. 1ABBV.MI Dividend Analysis

5.1 Amount

  • 1ABBV has a Yearly Dividend Yield of 3.30%. Purely for dividend investing, there may be better candidates out there.
  • Compared to an average industry Dividend Yield of 0.70, 1ABBV pays a better dividend. On top of this 1ABBV pays more dividend than 95.24% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.82, 1ABBV pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.3%

5.2 History

  • The dividend of 1ABBV is nicely growing with an annual growth rate of 6.76%!
Dividend Growth(5Y)6.76%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • 278.48% of the earnings are spent on dividend by 1ABBV. This is not a sustainable payout ratio.
  • 1ABBV's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP278.48%
EPS Next 2Y28.14%
EPS Next 3Y22.01%
1ABBV.MI Yearly Income VS Free CF VS Dividend1ABBV.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B
1ABBV.MI Dividend Payout.1ABBV.MI Dividend Payout, showing the Payout Ratio.1ABBV.MI Dividend Payout.PayoutRetained Earnings

1ABBV.MI Fundamentals: All Metrics, Ratios and Statistics

ABBVIE INC

BIT:1ABBV (4/9/2026, 7:00:00 PM)

180.75

+0.9 (+0.5%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-04
Earnings (Next)04-29
Inst Owners76.17%
Inst Owner ChangeN/A
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap319.60B
Revenue(TTM)61.16B
Net Income(TTM)4.19B
Analysts77.95
Price Target215.03 (18.97%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.3%
Yearly Dividend5.73
Dividend Growth(5Y)6.76%
DP278.48%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1.46%
Min EPS beat(2)0.18%
Max EPS beat(2)2.75%
EPS beat(4)4
Avg EPS beat(4)1.25%
Min EPS beat(4)0.18%
Max EPS beat(4)2.75%
EPS beat(8)8
Avg EPS beat(8)1.12%
EPS beat(12)10
Avg EPS beat(12)0.74%
EPS beat(16)12
Avg EPS beat(16)0.58%
Revenue beat(2)0
Avg Revenue beat(2)-0.79%
Min Revenue beat(2)-0.79%
Max Revenue beat(2)-0.78%
Revenue beat(4)2
Avg Revenue beat(4)0.07%
Min Revenue beat(4)-0.79%
Max Revenue beat(4)1.23%
Revenue beat(8)4
Avg Revenue beat(8)0.21%
Revenue beat(12)5
Avg Revenue beat(12)0.03%
Revenue beat(16)5
Avg Revenue beat(16)-0.64%
PT rev (1m)0.18%
PT rev (3m)0.73%
EPS NQ rev (1m)-3.54%
EPS NQ rev (3m)-1.6%
EPS NY rev (1m)2.19%
EPS NY rev (3m)2.16%
Revenue NQ rev (1m)-1.74%
Revenue NQ rev (3m)-1.02%
Revenue NY rev (1m)0.2%
Revenue NY rev (3m)0.6%
Valuation
Industry RankSector Rank
PE 21.29
Fwd PE 14.35
P/S 6.16
P/FCF 21.13
P/OCF 19.78
P/B N/A
P/tB N/A
EV/EBITDA 15
EPS(TTM)8.49
EY4.7%
EPS(NY)12.6
Fwd EY6.97%
FCF(TTM)8.55
FCFY4.73%
OCF(TTM)9.14
OCFY5.05%
SpS29.36
BVpS-1.57
TBVpS-43.95
PEG (NY)0.44
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA 3.12%
ROE N/A
ROCE 23.09%
ROIC 14.42%
ROICexc 15.28%
ROICexgc N/A
OM 34.23%
PM (TTM) 6.84%
GM 71.62%
FCFM 29.13%
ROA(3y)3.28%
ROA(5y)5.23%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)12.12%
ROIC(5y)11.88%
ROICexc(3y)13.19%
ROICexc(5y)12.96%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)19.1%
ROCE(5y)18.64%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y5.79%
ROICexc growth 5Y14.56%
OM growth 3Y-0.41%
OM growth 5Y2.75%
PM growth 3Y-30.39%
PM growth 5Y-7.2%
GM growth 3Y0.04%
GM growth 5Y1.44%
F-Score8
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 3.79
Debt/EBITDA 2.11
Cap/Depr 14.92%
Cap/Sales 1.98%
Interest Coverage 6.97
Cash Conversion 65.45%
Profit Quality 425.61%
Current Ratio 0.67
Quick Ratio 0.56
Altman-Z 2.33
F-Score8
WACC8.59%
ROIC/WACC1.68
Cap/Depr(3y)11.82%
Cap/Depr(5y)10.58%
Cap/Sales(3y)1.71%
Cap/Sales(5y)1.55%
Profit Quality(3y)434.7%
Profit Quality(5y)340.33%
High Growth Momentum
Growth
EPS 1Y (TTM)-1.19%
EPS 3Y-10.33%
EPS 5Y-0.99%
EPS Q2Q%25.46%
EPS Next Y48.4%
EPS Next 2Y28.14%
EPS Next 3Y22.01%
EPS Next 5Y15.08%
Revenue 1Y (TTM)8.57%
Revenue growth 3Y1.75%
Revenue growth 5Y5.95%
Sales Q2Q%10.04%
Revenue Next Year10.06%
Revenue Next 2Y9.09%
Revenue Next 3Y8.46%
Revenue Next 5Y6.43%
EBIT growth 1Y26.92%
EBIT growth 3Y1.33%
EBIT growth 5Y8.87%
EBIT Next Year42.07%
EBIT Next 3Y19.5%
EBIT Next 5Y10.21%
FCF growth 1Y-0.09%
FCF growth 3Y-9.76%
FCF growth 5Y1.19%
OCF growth 1Y1.19%
OCF growth 3Y-8.62%
OCF growth 5Y1.59%

ABBVIE INC / 1ABBV.MI Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for ABBVIE INC?

ChartMill assigns a fundamental rating of 5 / 10 to 1ABBV.MI.


What is the valuation status for 1ABBV stock?

ChartMill assigns a valuation rating of 7 / 10 to ABBVIE INC (1ABBV.MI). This can be considered as Undervalued.


How profitable is ABBVIE INC (1ABBV.MI) stock?

ABBVIE INC (1ABBV.MI) has a profitability rating of 7 / 10.


What is the financial health of ABBVIE INC (1ABBV.MI) stock?

The financial health rating of ABBVIE INC (1ABBV.MI) is 3 / 10.


What is the expected EPS growth for ABBVIE INC (1ABBV.MI) stock?

The Earnings per Share (EPS) of ABBVIE INC (1ABBV.MI) is expected to grow by 48.4% in the next year.